Clinical Trial Update: Cerebrospinal Fluid (CSF) Biomarkers Alzheimer's Disease (AD) and Non-AD Dementias

View source ↗

Summary

Clinical trial update reporting on a completed study evaluating cerebrospinal fluid biomarkers in Alzheimer's disease and non-Alzheimer's dementias.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia

Snippet

Sponsor: Duke University | Conditions: Alzheimer's Disease, Dementias | Status: COMPLETED